Figure 3
From: Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine
MDA-MB-231 cell survival after gemcitabine, nsPEFs and combined treatment - Experiments were carried out with MDA-MB-231 cells as described in Methods for survival 24 h (A) and 48 h (B). Synergism quotients (SQ) are shown for both treatment orders. The statistical significance among groups of nsPEFs, GEM and combination treatment was calculated with ANOVA analysis in SPSS. The significance between two groups (two orders of treatments) was calculated with Student-t test.